Literature DB >> 15834589

Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample.

Lauren A Weiss1, Mark Abney, Rodney Parry, Angelo M Scanu, Edwin H Cook, Carole Ober.   

Abstract

A recent genome-scan identified the Leu33Pro polymorphism in the beta3 integrin (ITGB3) gene as a quantitative trait locus for whole blood serotonin level in a large Hutterite pedigree. Because both the Leu33Pro polymorphism and the serotonin system have been implicated in cardiovascular disease (CVD) risk and treatment response, we studied additional variation in ITGB3 and its relationship to intermediate phenotypes associated with CVD in the same population. We examined associations between 15 single nucleotide polymorphisms (SNPs) across ITGB3 and five CVD-related traits in the Hutterites: plasma levels of high density lipoprotein-cholesterol (HDL-c), triglycerides (TG), low density lipoprotein-cholesterol (LDL-c), and lipoprotein(a) [Lp(a)] and blood pressure or hypertension. Seven of these SNPs in ITGB3 were associated with whole blood serotonin. Among the intermediate CVD-related phenotypes, only Lp(a) was associated with multiple ITGB3 SNPs, five of which were also associated with serotonin. A sex-stratified analysis revealed that the association between ITGB3 and Lp(a) is present only in females, whereas the association between ITGB3 and serotonin is concentrated in males. Our results suggest that variation in ITGB3 in addition to Leu33Pro could contribute to susceptibility to CVD and serotonin in a sex-specific manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834589     DOI: 10.1007/s00439-004-1250-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  46 in total

1.  Estimation of variance components of quantitative traits in inbred populations.

Authors:  M Abney; M S McPeek; C Ober
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

3.  A second-generation genomewide screen for asthma-susceptibility alleles in a founder population.

Authors:  C Ober; A Tsalenko; R Parry; N J Cox
Journal:  Am J Hum Genet       Date:  2000-10-05       Impact factor: 11.025

4.  Quantitative-trait homozygosity and association mapping and empirical genomewide significance in large, complex pedigrees: fasting serum-insulin level in the Hutterites.

Authors:  Mark Abney; Carole Ober; Mary Sara McPeek
Journal:  Am J Hum Genet       Date:  2002-03-04       Impact factor: 11.025

5.  Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration.

Authors:  R A Hegele; W C Breckenridge; J H Brunt; P W Connelly
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

6.  Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.

Authors:  E Farish; K Spowart; J F Barnes; C D Fletcher; A Calder; A Brown; D M Hart
Journal:  Atherosclerosis       Date:  1996-09-27       Impact factor: 5.162

7.  Birth size, growth, and blood pressure between the ages of 7 and 26 years: failure to support the fetal origins hypothesis.

Authors:  Sheila Williams; Richie Poulton
Journal:  Am J Epidemiol       Date:  2002-05-01       Impact factor: 4.897

8.  Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients.

Authors:  Jeanette J McCarthy; Joanne Meyer; David J Moliterno; L Kristin Newby; William J Rogers; Eric J Topol
Journal:  Hum Genet       Date:  2003-10-14       Impact factor: 4.132

9.  Are common disease susceptibility alleles the same in outbred and founder populations?

Authors:  Dina L Newman; Sabine Hoffjan; Catherine Bourgain; Mark Abney; Raluca I Nicolae; Elle T Profits; Michael A Grow; Karen Walker; Lori Steiner; Rodney Parry; Rebecca Reynolds; Mary Sara McPeek; Suzanne Cheng; Carole Ober
Journal:  Eur J Hum Genet       Date:  2004-07       Impact factor: 4.246

10.  Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.

Authors:  A M Carter; A J Catto; J M Bamford; P J Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-07       Impact factor: 8.311

View more
  12 in total

1.  Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.

Authors:  Ana M Coutinho; Inês Sousa; Madalena Martins; Catarina Correia; Teresa Morgadinho; Celeste Bento; Carla Marques; Assunção Ataíde; Teresa S Miguel; Jason H Moore; Guiomar Oliveira; Astrid M Vicente
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

2.  ITGB3 shows genetic and expression interaction with SLC6A4.

Authors:  Lauren A Weiss; Carole Ober; Edwin H Cook
Journal:  Hum Genet       Date:  2006-05-24       Impact factor: 4.132

3.  New complexities in the genetics of stuttering: significant sex-specific linkage signals.

Authors:  Rathi Suresh; Nicoline Ambrose; Cheryl Roe; Anna Pluzhnikov; Jacqueline K Wittke-Thompson; Maggie C-Y Ng; Xiaolin Wu; Edwin H Cook; Cecilia Lundstrom; Marie Garsten; Ruth Ezrati; Ehud Yairi; Nancy J Cox
Journal:  Am J Hum Genet       Date:  2006-02-01       Impact factor: 11.025

4.  Campora: a young genetic isolate in South Italy.

Authors:  Vincenza Colonna; Teresa Nutile; Maria Astore; Ombretta Guardiola; Giuliano Antoniol; Marina Ciullo; M Graziella Persico
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

5.  Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.

Authors:  Carole Ober; Alex S Nord; Emma E Thompson; Lin Pan; Zheng Tan; Darren Cusanovich; Ying Sun; Raluca Nicolae; Celina Edelstein; Daniel H Schneider; Christine Billstrand; Ditta Pfaffinger; Natasha Phillips; Rebecca L Anderson; Binu Philips; Ramakrishnan Rajagopalan; Thomas S Hatsukami; Mark J Rieder; Patrick J Heagerty; Deborah A Nickerson; Mark Abney; Santica Marcovina; Gail P Jarvik; Angelo M Scanu; Dan L Nicolae
Journal:  J Lipid Res       Date:  2009-01-05       Impact factor: 5.922

6.  Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism.

Authors:  Sarah Cross; Soo-Jeong Kim; Lauren A Weiss; Ryan J Delahanty; James S Sutcliffe; Bennett L Leventhal; Edwin H Cook; Jeremy Veenstra-Vanderweele
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

7.  Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey.

Authors:  Man-huei Chang; Ajay Yesupriya; Renée M Ned; Patricia W Mueller; Nicole F Dowling
Journal:  BMC Med Genet       Date:  2010-04-20       Impact factor: 2.103

8.  Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.

Authors:  Moritz Eidens; Alexander Weise; Stefan Prause; Norbert Dahmen; Annette Wunsch; Mathias Max Weber; Thomas Forst; Andreas Pfützner
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice.

Authors:  R Ye; A M D Carneiro; D Airey; E Sanders-Bush; R W Williams; L Lu; J Wang; B Zhang; R D Blakely
Journal:  Genes Brain Behav       Date:  2013-10-31       Impact factor: 3.449

10.  Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects.

Authors:  Mu-Peng Li; Yan Xiong; An Xu; Ji-Peng Zhou; Jie Tang; Zan-Ling Zhang; Hong-Hao Zhou; Wei Zhang; Xiao-Ping Chen
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.